180 related articles for article (PubMed ID: 37497710)
1. Recent Advancement in Bioactive Chalcone Hybrids as Potential Antimicrobial Agents in Medicinal Chemistry.
Maurya A; Agrawal A
Mini Rev Med Chem; 2024; 24(2):176-195. PubMed ID: 37497710
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives.
Dhaliwal JS; Moshawih S; Goh KW; Loy MJ; Hossain MS; Hermansyah A; Kotra V; Kifli N; Goh HP; Dhaliwal SKS; Yassin H; Ming LC
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296655
[TBL] [Abstract][Full Text] [Related]
3. Chalcone Derivatives: Role in Anticancer Therapy.
Ouyang Y; Li J; Chen X; Fu X; Sun S; Wu Q
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208562
[TBL] [Abstract][Full Text] [Related]
4. Exploring pharmacological significance of chalcone scaffold: a review.
Sahu NK; Balbhadra SS; Choudhary J; Kohli DV
Curr Med Chem; 2012; 19(2):209-25. PubMed ID: 22320299
[TBL] [Abstract][Full Text] [Related]
5. The Quinazoline-Chalcone and Quinazolinone-Chalcone Hybrids: A Promising Combination for Biological Activity.
Mass EB; Duarte GV; Russowsky D
Mini Rev Med Chem; 2021; 21(2):186-203. PubMed ID: 32744973
[TBL] [Abstract][Full Text] [Related]
6. Chalcones: Synthetic Chemistry Follows Where Nature Leads.
Jasim HA; Nahar L; Jasim MA; Moore SA; Ritchie KJ; Sarker SD
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439870
[TBL] [Abstract][Full Text] [Related]
7. Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents.
Yang J; Lv J; Cheng S; Jing T; Meng T; Huo D; Ma X; Wen R
Anticancer Agents Med Chem; 2023; 23(11):1265-1283. PubMed ID: 36825723
[TBL] [Abstract][Full Text] [Related]
8. Chalcone Scaffolds as Anticancer Drugs: A Review on Molecular Insight in Action of Mechanisms and Anticancer Properties.
Shukla S; Sood AK; Goyal K; Singh A; Sharma V; Guliya N; Gulati S; Kumar S
Anticancer Agents Med Chem; 2021; 21(13):1650-1670. PubMed ID: 33238850
[TBL] [Abstract][Full Text] [Related]
9. Heterocyclic chalcone analogues as potential anticancer agents.
Sharma V; Kumar V; Kumar P
Anticancer Agents Med Chem; 2013 Mar; 13(3):422-32. PubMed ID: 22721390
[TBL] [Abstract][Full Text] [Related]
10. Recent developments of chalcones as potential antibacterial agents in medicinal chemistry.
Dan W; Dai J
Eur J Med Chem; 2020 Feb; 187():111980. PubMed ID: 31877539
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, reactions and application of chalcones: a systematic review.
Shalaby MA; Rizk SA; Fahim AM
Org Biomol Chem; 2023 Jul; 21(26):5317-5346. PubMed ID: 37338020
[TBL] [Abstract][Full Text] [Related]
12. Bioactivities of chalcones.
Dimmock JR; Elias DW; Beazely MA; Kandepu NM
Curr Med Chem; 1999 Dec; 6(12):1125-49. PubMed ID: 10519918
[TBL] [Abstract][Full Text] [Related]
13. Current Discovery Progress of Some Emerging Anti-infective Chalcones: Highlights from 2016 to 2017.
Mahapatra DK; Ghorai S; Bharti SK; Patil AG; Gayen S
Curr Drug Discov Technol; 2020; 17(1):30-44. PubMed ID: 30033873
[TBL] [Abstract][Full Text] [Related]
14. Anticancer Activity of Natural and Synthetic Chalcones.
Constantinescu T; Lungu CN
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768736
[TBL] [Abstract][Full Text] [Related]
15. Potential pharmacological uses of chalcones: a patent review (from June 2011 - 2014).
Matos MJ; Vazquez-Rodriguez S; Uriarte E; Santana L
Expert Opin Ther Pat; 2015 Mar; 25(3):351-66. PubMed ID: 25598152
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial, Antiproliferative Effects and Docking Studies of Methoxy Group Enriched Coumarin-Chalcone Hybrids.
Badreddin Musatat A; Kılıçcıoğlu İ; Kurman Y; Dülger G; Alpay M; Yağcı R; Atahan A; Durmuş S
Chem Biodivers; 2023 Mar; 20(3):e202200973. PubMed ID: 36691991
[TBL] [Abstract][Full Text] [Related]
17. Chalcones: Promising therapeutic agents targeting key players and signaling pathways regulating the hallmarks of cancer.
WalyEldeen AA; Sabet S; El-Shorbagy HM; Abdelhamid IA; Ibrahim SA
Chem Biol Interact; 2023 Jan; 369():110297. PubMed ID: 36496109
[TBL] [Abstract][Full Text] [Related]
18. Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure-activity relationship.
Gao F; Huang G; Xiao J
Med Res Rev; 2020 Sep; 40(5):2049-2084. PubMed ID: 32525247
[TBL] [Abstract][Full Text] [Related]
19. Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications.
Mahapatra DK; Bharti SK; Asati V; Singh SK
Eur J Med Chem; 2019 Jul; 174():142-158. PubMed ID: 31035237
[TBL] [Abstract][Full Text] [Related]
20. Identification of quinoline-chalcones and heterocyclic chalcone-appended quinolines as broad-spectrum pharmacological agents.
Atukuri D; S V; R S; L V; R P; M M R
Bioorg Chem; 2020 Dec; 105():104419. PubMed ID: 33142228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
